In vitro sustained release of bioactive anti-NogoA, a molecule in clinical development for treatment of spinal cord injury

International Journal of Pharmaceutics

Volumn 426, Issue 1-2, 2012, Pages 284-290

  Stanwick, Jason C ^a   Baumann, M Douglas ^a,b   Shoichet, Molly S ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Anti NogoA (11c7); Drug delivery; Hydrogel; Nanoparticle; Poly(lactic co glycolic acid) (PLGA)

Indexed keywords

ANTIBODY; ANTINEURITE OUTGROWTH INHIBITOR A; HYALURONIC ACID; MAGNESIUM CARBONATE; METHYLCELLULOSE; POLYGLACTIN; TREHALOSE; UNCLASSIFIED DRUG;

ALKALINITY; ARTICLE; DENATURATION; DRUG ACTIVITY; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; FREEZE DRYING; HYDROGEL; HYDROLYSIS; IN VITRO STUDY; IN VIVO STUDY; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; SPINAL CORD INJURY; SUSTAINED DRUG RELEASE; VISCOSITY;

ANTIBODIES, MONOCLONAL; CALCIUM CARBONATE; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXCIPIENTS; FREEZE DRYING; HYALURONIC ACID; HYDROGELS; KINETICS; LACTIC ACID; MAGNESIUM; METHYLCELLULOSE; MYELIN PROTEINS; NANOPARTICLES; NANOTECHNOLOGY; POLYGLYCOLIC ACID; POLYMERS; SOLUBILITY; SPINAL CORD INJURIES; TECHNOLOGY, PHARMACEUTICAL; TREHALOSE;

EID: 84857785798     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.01.035     Document Type: Article

References (39)

1. D. Aprili, O. Bandschapp, C. Rochlitz, A. Urwyler, and W. Ruppen Serious complications associated with external intrathecal catheters used in cancer pain patients: a systematic review and meta-analysis Anesthesiology 111 2009 1346 1355
2. M. Ara, M. Watanabe, and Y. Imai Effect of blending calcium compounds on hydrolytic degradation of poly(dl-lactic acid-co-glycolic acid) Biomaterials 23 2002 2479 2483 (Pubitemid 34288489)
3. A. Baker, H. Kim, J.L. Semple, D. Dumont, M. Shoichet, D. Tobbia, and M. Johnston Experimental assessment of pro-lymphangiogenic growth factors in the treatment of post-surgical lymphedema following lymphadenectomy Breast Cancer Res. 12 2010 70
4. M.D. Baumann, J.W. Austin, M.G. Fehlings, and M.S. Shoichet A quantitative ELISA for bioactive anti-Nogo-A, a promising regenerative molecule for spinal cord injury repair Methods 44 2009 104 108
5. M.D. Baumann, C.E. Kang, J.C. Stanwick, Y. Wang, H. Kim, Y. Lapitsky, and M.S. Shoichet An injectable drug delivery platform for sustained combination therapy J. Control. Release 138 2009 205 213
6. M.D. Baumann, C.E. Kang, C.H. Tator, and M.S. Shoichet Intrathecal delivery of a polymeric nanocomposite hydrogel after spinal cord injury Biomaterials 31 2010 7631 7639
7. U. Bilati, E. Allemann, and E. Doelker Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles Eur. J. Pharm. Sci. 59 2005 375 388 (Pubitemid 40342512)
8. A. Budhian, S.J. Siegel, and K.I. Winey Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles Int. J. Pharm. 346 2008 151 159 (Pubitemid 350101995)
9. J.F. Carpenter, J.H. Crowe, and T. Arakawa Comparison of solute-induced protein stabilization in aqueous solution and in frozen and dried state J. Dairy Sci. 73 1990 3627 3636
10. M. Chorny, I. Fishbein, H.D. Danenberg, and G. Golomb Study of drug release mechanism from tyrophostin AG-1295-loaded nanospheres by in situ and external sink methods J. Control. Release 83 2002 401 414 (Pubitemid 35223262)
11. Clinicaltrials.gov Acute Safety, Tolerability, Feasibility and Pharmacokinetics of Intrath. Administered ATI355 in Patients With Acute SCI 2011 Clinicaltrials.gov
12. W.M. Deen Hindered transport of large molecules in liquid-filled pores AIChE 33 1987 1409 1425 (Pubitemid 17654407)
13. R. Dorati, C. Colonna, I. Genta, T. Modena, and B. Conti Effect of porogen on the physico-chemical properties and degradation performance of PLGA scaffolds Polym. Degrad. Stabil. 95 2010 694 701
14. N. Faisant, J. Siepmann, and J.P. Benoit PLGA-based microparticles: elucidation of mechanisms and a new, simple mathematical model quantifying drug release Eur. J. Pharm. Sci. 15 2002 355 366 (Pubitemid 34436923)
15. P. Freund, E. Schmidlin, T. Wannier, J. Bloch, A. Mir, M.E. Schwab, and E.M. Rouiller Nogo-A-specific antibody treatment enhances sprouting and functional recovery after cervical lesion in adult primates Nat. Med. 12 2006 790 792 (Pubitemid 44050068)
16. A. Giteau, M.C. Venier-Julienne, A. Aubert-Pouessel, and J.P. Benoit How to achieve sustained and complete protein release from PLGA-based microparticles Int. J. Pharm. 350 2008 14 26
17. D. Gupta, C.H. Tator, and M.S. Shoichet Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord Biomaterials 27 2006 2370 2379 (Pubitemid 41821815)
18. Y. Han, B.-Y. Jin, S.-B. Lee, Y. Sohn, J.-W. Joung, and J.-H. Lee Effects of sugar additives on protein stability of recombinant human serum albumin during lyophilization and storage Arch. Pharm. Res. 30 2007 1124 1131
19. G.W.J. Hawryluk, J. Rowland, B.K. Kwon, and M.G. Fehlings Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury Neurosurg. Focus 25 2008 E14
20. W. Jiang, and S.P. Schwendeman Stabilization of tetanus toxoid encapsulated in PLGA microspheres Mol. Pharm. 5 2008 808 817
21. C.E. Kang, P.C. Poon, and M.S. Shoichet A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair Tissue Eng.: Part A 15 2009 595 604
22. C.E. Kang, R. Clarkson, C.H. Tator, I.W.T. Yeung, and M.S. Shoichet Spinal cord blood flow and blood vessel permeability measured by dynamic computed tomography imaging in rats after localized delivery of fibroblast growth factor J. Neurotrauma 27 2010 2041 2053
23. 2 and sucrose on the stability of bovine serum albumin encapsulated in injectable poly(d,l-lactide-co-glycolide) implants Biomaterials 23 2002 239 245 (Pubitemid 33041359)
24. O. Karal-Yilmaz, M. Serhatli, K. Baysal, and B.M. Baysal Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(d,l-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique J. Microencapsul. 1 2011 46 54
25. J.B. Leach, K.A. Bivens, C.W. Patrick Jr., and C.E. Schmidt Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds Biotechnol. Bioeng. 82 2003 578 589 (Pubitemid 36514267)
26. D.H.S. Lee, S.M. Strittmatter, and D.W.Y. Sah Targeting the nogo receptor to treat central nervous system injuries Nat. Rev. Drug Discov. 2 2003 872 878 (Pubitemid 37407793)
27. E.S. Lee, M.J. Kwon, H. Lee, and J.J. Kim Stabilization of protein encapsulated in poly(lactide-co-glycolide) microspheres by novel viscous S/W/O/W method Int. J. Pharm. 331 2007 27 37 (Pubitemid 46176493)
28. L. Li, and S.P. Schwendeman Mapping neutral microclimate pH in PLGA microspheres J. Control. Release 101 2005 163 173 (Pubitemid 39600980)
29. T. Liebscher, L. Schnell, D. Schnell, J. Scholl, R. Schneider, M. Gullo, K. Fouad, A. Mir, M. Rausch, D. Kindler, F.P.T. Hamers, and M.E. Schwab Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats Ann. Neurol. 58 2005 706 719 (Pubitemid 41552546)
30. P. Matin, and D.A. Goodwin Cerebrospinal fluid scanning with 111 Int. J. Nucl. Med. 12 1971 668 672
31. T. Oertle, M.E. van der Haar, and C.E. Bandtlow Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions J. Neurosci. 23 2003 5393 5406 (Pubitemid 36807813)
32. C. Raman, C. Berkland, K. Kim, and D.W. Pack Modeling small-molecule release from PLG microspheres: effects of polymer degradation and nonuniform drug distribution J. Control. Release 103 2005 149 158 (Pubitemid 40248569)
33. C. Rouzes, M. Leonard, A. Durand, and E. Dellacherie Influence of polymeric surfactants on the properties of drug-loaded PLA nanospheres Colloid Surf. B: Biointerfaces 32 2003 125 135 (Pubitemid 37083519)
34. S. Thuret, L.D.F. Moon, and F.H. Gage Therapeutic interventions after spinal cord injury Nature 7 2006 628 643 (Pubitemid 44106745)
35. C.F. van der Walle, G. Sharma, and M.N.V.R. Kumar Current approaches to stabilising and analysing proteins during microencapsulation in PLGA Expert Opin. Drug Deliv. 6 2009 177 186
36. W. Wang Lyophilization and development of solid protein pharmaceuticals Int. J. Pharm. 203 2000 1 60 (Pubitemid 30627625)
37. J. Wu, H. Yang, Z. Qiu, Q. Zhang, T. Ding, and D. Geng Effect of combined treatment with methylprednisolone and nogo-A monoclonal antibody after rat spinal cord injury J. Int. Med. Res. 38 2010 570 582
38. Y. Yeo, and K. Park Control of encapsulation efficiency and initial burst in polymeric microparticle systems Arch. Pharm. Res. 27 2004 1 12 (Pubitemid 43158226)
39. G. Zhu, S.R. Mallery, and S.P. Schwendeman Stabilization of proteins encapsulated in injectable poly(lactide-co-glycolide) Nat. Biotechnol. 18 2000 52 57 (Pubitemid 30041172)